NCT00638911View on ClinicalTrials.gov

Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential Hypertension

CompletedOBSERVATIONAL
Enrollment

33,247

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

October 31, 2009

Conditions
Hypertension
Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00638911 - Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential Hypertension | Biotech Hunter | Biotech Hunter